Pheochromocytomas and paragangliomas.

ABSTRACT:

Purpose of review

Great progress has been made in understanding the genetic and molecular basis of pheochromocytoma and paragangliomas (PPGLs). This review highlights the new standards in the diagnosis and management of pediatric PPGLs.

Recent findings

The vast majority of pediatric PPGLs have an associated germline mutation, making genetic studies imperative in the work up of these tumors. Somatostatin receptor-based imaging modalities such as 68Ga-DOTATATE and 64Cu-DOTATATE are shown to have the greatest sensitivity in pediatric PPGLs. Peptide receptor radionuclide therapies (PRRTs) such as 177Lu-DOTATATE are shown to have efficacy for treating PPGLs.

Summary

Genetics play an important role in pediatric PPGLs. Advances in somatostatin receptor-based technology have

SUBMITTER: Yen K 

PROVIDER: S-EPMC10122989 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature